Subjective ibogaine experiences across intersecting social-ecological dimensions
Evan E. Ozmat, Alicia K. Mcdonough, Guy M. Ladouceur, Darin S. Roy, Dana M. Bozek, Jun-sung Oh, Jessica L. Martin
Journal of Psychedelic Studies May 31, 2024 Peer reviewed DOI: 10.1556/2054.2024.00322 via OpenAlex
Summary
Ibogaine treatment led to significant improvements in addiction recovery for individuals who had previously struggled with other services. Participants reported reduced cravings and withdrawal symptoms, as well as gaining insights into their addictions. The study involved 15 individuals who shared their experiences through interviews, highlighting the importance of self-support and communication about ibogaine experiences for recovery. Most sought mental health support after treatment, despite prior negative experiences with behavioral health systems.
Study at a glance
| Design | qualitative study |
|---|---|
| Sample size | 15 |
| Population | individuals seeking ibogaine treatment for addictions |
| Key finding | Participants experienced enduring positive impacts on their addiction recovery following ibogaine treatment, despite previous challenges with behavioral health systems. |
Abstract
Abstract Background and aims Ibogaine, an alkaloid extracted from the root of the Tabernanthe Iboga shrub, holds promise in treating addictive disorders. Individuals receiving ibogaine treatment report decreased withdrawal symptoms, cravings, and addiction severity. These changes are often attributed to ibogaine's psychedelic properties: subjectively meaningful, dream-like experiences. Research demonstrates that ibogaine experiences impact multiple social-ecological dimensions and influence addiction and recovery trajectories. No studies have explored the multidimensional experiences of individuals seeking ibogaine treatment for addictions. The current study examines acute and enduring ibogaine experiences at individual, interpersonal, and behavioral health systems levels. Methods Fifteen individuals (5 female, 10 male) who received ibogaine treatment at a medical clinic in Ensenada, Mexico completed semi-structured interviews asking about individual, interpersonal, and behavioral health system experiences post-ibogaine within 12 months of ibogaine treatment ( Mdn = 169 days). Transcripts were coded and analyzed using a Consensual Qualitative Research approach. Results Many participants reported seeking ibogaine treatment after exhausting other addiction services. Outcomes reported following treatment included alleviated cravings and withdrawal symptoms. Participants indicated that ibogaine experiences prompted insight into their addictions and contributed to their recovery. Self-support and disclosing ibogaine experiences to professional and non-professional supporters were important to participants' recovery post-ibogaine. Conclusions Intersecting experiences across social-ecological levels had an enduring impact on participants' addiction recovery after ibogaine treatment. Despite negative experiences with behavioral health systems prior to receiving ibogaine treatment, most participants sought the support of mental health professionals post-ibogaine. Findings are informative for mental health professionals and clients interested in ibogaine treatment.